nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexamethasone—ulcerative colitis—celiac disease	0.907	1	CtDrD
Dexamethasone—ABCB11—bile—celiac disease	0.00912	0.107	CbGeAlD
Dexamethasone—ABCC2—bile—celiac disease	0.00464	0.0545	CbGeAlD
Dexamethasone—ANXA1—gall bladder—celiac disease	0.00249	0.0292	CbGeAlD
Dexamethasone—CYP2C19—urine—celiac disease	0.00217	0.0255	CbGeAlD
Dexamethasone—PLA2G1B—connective tissue—celiac disease	0.00177	0.0208	CbGeAlD
Dexamethasone—NR3C1—urine—celiac disease	0.0017	0.0199	CbGeAlD
Dexamethasone—PLA2G1B—epithelium—celiac disease	0.00168	0.0198	CbGeAlD
Dexamethasone—CYP2C9—urine—celiac disease	0.00168	0.0198	CbGeAlD
Dexamethasone—CYP3A43—liver—celiac disease	0.00162	0.019	CbGeAlD
Dexamethasone—CYP2E1—urine—celiac disease	0.00159	0.0187	CbGeAlD
Dexamethasone—CYP4A11—digestive system—celiac disease	0.00155	0.0182	CbGeAlD
Dexamethasone—PLA2G1B—pancreas—celiac disease	0.0015	0.0176	CbGeAlD
Dexamethasone—ANXA1—connective tissue—celiac disease	0.00136	0.0159	CbGeAlD
Dexamethasone—ANXA1—epithelium—celiac disease	0.00129	0.0151	CbGeAlD
Dexamethasone—CYP3A4—urine—celiac disease	0.00128	0.0151	CbGeAlD
Dexamethasone—PLA2G1B—digestive system—celiac disease	0.00128	0.015	CbGeAlD
Dexamethasone—CYP2D6—urine—celiac disease	0.00126	0.0148	CbGeAlD
Dexamethasone—ANXA1—smooth muscle tissue—celiac disease	0.00124	0.0146	CbGeAlD
Dexamethasone—PLA2G1B—blood—celiac disease	0.00122	0.0143	CbGeAlD
Dexamethasone—CYP17A1—connective tissue—celiac disease	0.00122	0.0143	CbGeAlD
Dexamethasone—CYP4A11—liver—celiac disease	0.00115	0.0135	CbGeAlD
Dexamethasone—ANXA1—pancreas—celiac disease	0.00115	0.0135	CbGeAlD
Dexamethasone—CYP11A1—connective tissue—celiac disease	0.00113	0.0133	CbGeAlD
Dexamethasone—ABCB11—digestive system—celiac disease	0.000996	0.0117	CbGeAlD
Dexamethasone—ANXA1—lymphoid tissue—celiac disease	0.000992	0.0116	CbGeAlD
Dexamethasone—ANXA1—digestive system—celiac disease	0.00098	0.0115	CbGeAlD
Dexamethasone—ANXA1—blood—celiac disease	0.000933	0.011	CbGeAlD
Dexamethasone—NR3C2—connective tissue—celiac disease	0.000878	0.0103	CbGeAlD
Dexamethasone—PGR—connective tissue—celiac disease	0.000817	0.00959	CbGeAlD
Dexamethasone—NR3C2—smooth muscle tissue—celiac disease	0.000804	0.00944	CbGeAlD
Dexamethasone—CYP11A1—blood—celiac disease	0.000778	0.00914	CbGeAlD
Dexamethasone—PGR—epithelium—celiac disease	0.000775	0.0091	CbGeAlD
Dexamethasone—PTGS2—gall bladder—celiac disease	0.000748	0.00879	CbGeAlD
Dexamethasone—PGR—smooth muscle tissue—celiac disease	0.000747	0.00877	CbGeAlD
Dexamethasone—ABCB11—liver—celiac disease	0.000742	0.00872	CbGeAlD
Dexamethasone—CYP19A1—connective tissue—celiac disease	0.000735	0.00863	CbGeAlD
Dexamethasone—ANXA1—liver—celiac disease	0.00073	0.00857	CbGeAlD
Dexamethasone—CYP3A7—liver—celiac disease	0.000726	0.00853	CbGeAlD
Dexamethasone—CYP1B1—connective tissue—celiac disease	0.000687	0.00807	CbGeAlD
Dexamethasone—CYP17A1—liver—celiac disease	0.000654	0.00768	CbGeAlD
Dexamethasone—NR3C2—digestive system—celiac disease	0.000634	0.00745	CbGeAlD
Dexamethasone—CYP1B1—smooth muscle tissue—celiac disease	0.000628	0.00738	CbGeAlD
Dexamethasone—NOS2—IL23-mediated signaling events—IL23R—celiac disease	0.000619	0.0832	CbGpPWpGaD
Dexamethasone—CYP3A7-CYP3A51P—liver—celiac disease	0.000617	0.00725	CbGeAlD
Dexamethasone—NR3C2—blood—celiac disease	0.000604	0.0071	CbGeAlD
Dexamethasone—PGR—lymphoid tissue—celiac disease	0.000597	0.00701	CbGeAlD
Dexamethasone—NOS2—IL23-mediated signaling events—IL18RAP—celiac disease	0.00059	0.0794	CbGpPWpGaD
Dexamethasone—NOS2—Alpha9 beta1 integrin signaling events—TGM2—celiac disease	0.000575	0.0774	CbGpPWpGaD
Dexamethasone—PGR—blood—celiac disease	0.000562	0.0066	CbGeAlD
Dexamethasone—SLCO1A2—digestive system—celiac disease	0.000544	0.00639	CbGeAlD
Dexamethasone—ABCC2—digestive system—celiac disease	0.000507	0.00595	CbGeAlD
Dexamethasone—CYP19A1—blood—celiac disease	0.000506	0.00594	CbGeAlD
Dexamethasone—CYP2A6—liver—celiac disease	0.000504	0.00592	CbGeAlD
Dexamethasone—CYP1B1—lymphoid tissue—celiac disease	0.000502	0.0059	CbGeAlD
Dexamethasone—CYP1B1—digestive system—celiac disease	0.000496	0.00583	CbGeAlD
Dexamethasone—ABCC2—blood—celiac disease	0.000483	0.00567	CbGeAlD
Dexamethasone—CYP1B1—blood—celiac disease	0.000473	0.00555	CbGeAlD
Dexamethasone—NR3C2—liver—celiac disease	0.000473	0.00555	CbGeAlD
Dexamethasone—NR3C1—connective tissue—celiac disease	0.000471	0.00553	CbGeAlD
Dexamethasone—CYP1A1—epithelium—celiac disease	0.000461	0.00541	CbGeAlD
Dexamethasone—NR3C1—epithelium—celiac disease	0.000447	0.00525	CbGeAlD
Dexamethasone—CYP2C19—digestive system—celiac disease	0.000435	0.00511	CbGeAlD
Dexamethasone—NR3C1—smooth muscle tissue—celiac disease	0.000431	0.00506	CbGeAlD
Dexamethasone—CYP2C19—blood—celiac disease	0.000415	0.00487	CbGeAlD
Dexamethasone—PTGS2—connective tissue—celiac disease	0.000408	0.00479	CbGeAlD
Dexamethasone—SLCO1A2—liver—celiac disease	0.000405	0.00476	CbGeAlD
Dexamethasone—CYP3A5—pancreas—celiac disease	0.000402	0.00472	CbGeAlD
Dexamethasone—NOS2—IL12-mediated signaling events—IL18RAP—celiac disease	0.000401	0.0539	CbGpPWpGaD
Dexamethasone—NR3C1—pancreas—celiac disease	0.000398	0.00468	CbGeAlD
Dexamethasone—CYP19A1—liver—celiac disease	0.000395	0.00464	CbGeAlD
Dexamethasone—PTGS2—epithelium—celiac disease	0.000387	0.00455	CbGeAlD
Dexamethasone—ABCC2—liver—celiac disease	0.000377	0.00443	CbGeAlD
Dexamethasone—PTGS2—smooth muscle tissue—celiac disease	0.000373	0.00438	CbGeAlD
Dexamethasone—CYP1B1—liver—celiac disease	0.00037	0.00434	CbGeAlD
Dexamethasone—CYP2C8—blood—celiac disease	0.000362	0.00425	CbGeAlD
Dexamethasone—ABCG2—blood—celiac disease	0.000352	0.00413	CbGeAlD
Dexamethasone—CYP1A1—digestive system—celiac disease	0.000351	0.00412	CbGeAlD
Dexamethasone—CYP2B6—lymphoid tissue—celiac disease	0.000345	0.00405	CbGeAlD
Dexamethasone—PTGS2—pancreas—celiac disease	0.000345	0.00405	CbGeAlD
Dexamethasone—NR3C1—lymphoid tissue—celiac disease	0.000345	0.00405	CbGeAlD
Dexamethasone—CYP3A5—digestive system—celiac disease	0.000343	0.00403	CbGeAlD
Dexamethasone—CYP2B6—digestive system—celiac disease	0.000341	0.004	CbGeAlD
Dexamethasone—NR3C1—digestive system—celiac disease	0.00034	0.004	CbGeAlD
Dexamethasone—CYP2C9—digestive system—celiac disease	0.000338	0.00396	CbGeAlD
Dexamethasone—CYP1A1—blood—celiac disease	0.000334	0.00392	CbGeAlD
Dexamethasone—CYP3A5—blood—celiac disease	0.000327	0.00384	CbGeAlD
Dexamethasone—CYP2B6—blood—celiac disease	0.000325	0.00381	CbGeAlD
Dexamethasone—CYP2C19—liver—celiac disease	0.000324	0.00381	CbGeAlD
Dexamethasone—NR3C1—blood—celiac disease	0.000324	0.00381	CbGeAlD
Dexamethasone—CYP2E1—lymphoid tissue—celiac disease	0.000324	0.0038	CbGeAlD
Dexamethasone—CYP2C9—blood—celiac disease	0.000322	0.00378	CbGeAlD
Dexamethasone—CYP2E1—digestive system—celiac disease	0.00032	0.00376	CbGeAlD
Dexamethasone—CYP2E1—blood—celiac disease	0.000305	0.00358	CbGeAlD
Dexamethasone—PTGS2—lymphoid tissue—celiac disease	0.000298	0.0035	CbGeAlD
Dexamethasone—PTGS2—digestive system—celiac disease	0.000295	0.00346	CbGeAlD
Dexamethasone—CYP2C8—liver—celiac disease	0.000283	0.00332	CbGeAlD
Dexamethasone—PTGS2—blood—celiac disease	0.000281	0.0033	CbGeAlD
Dexamethasone—ABCG2—liver—celiac disease	0.000275	0.00323	CbGeAlD
Dexamethasone—CYP1A1—liver—celiac disease	0.000261	0.00307	CbGeAlD
Dexamethasone—CYP3A4—digestive system—celiac disease	0.000257	0.00302	CbGeAlD
Dexamethasone—CYP3A5—liver—celiac disease	0.000255	0.003	CbGeAlD
Dexamethasone—CYP2B6—liver—celiac disease	0.000254	0.00298	CbGeAlD
Dexamethasone—NR3C1—liver—celiac disease	0.000254	0.00298	CbGeAlD
Dexamethasone—CYP2D6—digestive system—celiac disease	0.000253	0.00297	CbGeAlD
Dexamethasone—CYP2C9—liver—celiac disease	0.000251	0.00295	CbGeAlD
Dexamethasone—NOS2—IL12-mediated signaling events—IL12A—celiac disease	0.000248	0.0333	CbGpPWpGaD
Dexamethasone—NOS2—IL23-mediated signaling events—IL17A—celiac disease	0.000246	0.0331	CbGpPWpGaD
Dexamethasone—CYP3A4—blood—celiac disease	0.000245	0.00288	CbGeAlD
Dexamethasone—CYP2D6—blood—celiac disease	0.000241	0.00283	CbGeAlD
Dexamethasone—ABCB1—epithelium—celiac disease	0.000239	0.00281	CbGeAlD
Dexamethasone—CYP2E1—liver—celiac disease	0.000238	0.0028	CbGeAlD
Dexamethasone—PTGS2—liver—celiac disease	0.000219	0.00258	CbGeAlD
Dexamethasone—ABCB1—pancreas—celiac disease	0.000213	0.00251	CbGeAlD
Dexamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTPRK—celiac disease	0.000204	0.0274	CbGpPWpGaD
Dexamethasone—ANXA1—Integrated Breast Cancer Pathway—ZMIZ1—celiac disease	0.000193	0.0259	CbGpPWpGaD
Dexamethasone—CYP3A4—liver—celiac disease	0.000192	0.00225	CbGeAlD
Dexamethasone—CYP2D6—liver—celiac disease	0.000189	0.00222	CbGeAlD
Dexamethasone—ABCB1—lymphoid tissue—celiac disease	0.000184	0.00217	CbGeAlD
Dexamethasone—ABCB1—digestive system—celiac disease	0.000182	0.00214	CbGeAlD
Dexamethasone—ABCB1—blood—celiac disease	0.000174	0.00204	CbGeAlD
Dexamethasone—NOS2—HIF-1-alpha transcription factor network—ETS1—celiac disease	0.00017	0.0228	CbGpPWpGaD
Dexamethasone—ANXA1—Spinal Cord Injury—FCGR2A—celiac disease	0.000142	0.0191	CbGpPWpGaD
Dexamethasone—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL12A—celiac disease	0.00014	0.0189	CbGpPWpGaD
Dexamethasone—ABCB1—liver—celiac disease	0.000136	0.00159	CbGeAlD
Dexamethasone—ANXA1—G alpha (i) signalling events—RGS1—celiac disease	0.000127	0.0171	CbGpPWpGaD
Dexamethasone—ABCG2—HIF-2-alpha transcription factor network—ETS1—celiac disease	0.00012	0.0161	CbGpPWpGaD
Dexamethasone—ANXA1—Peptide ligand-binding receptors—CCR4—celiac disease	0.000116	0.0157	CbGpPWpGaD
Dexamethasone—NOS2—IL12-mediated signaling events—CD8A—celiac disease	0.000112	0.0151	CbGpPWpGaD
Dexamethasone—ABCB1—Allograft Rejection—MICA—celiac disease	0.000112	0.0151	CbGpPWpGaD
Dexamethasone—ABCB1—Allograft Rejection—IL21—celiac disease	0.000112	0.0151	CbGpPWpGaD
Dexamethasone—NOS2—Spinal Cord Injury—FCGR2A—celiac disease	0.000107	0.0144	CbGpPWpGaD
Dexamethasone—ANXA1—Peptide ligand-binding receptors—CCR3—celiac disease	9.9e-05	0.0133	CbGpPWpGaD
Dexamethasone—ANXA1—G alpha (i) signalling events—CCR4—celiac disease	9.82e-05	0.0132	CbGpPWpGaD
Dexamethasone—NOS2—IL23-mediated signaling events—CD4—celiac disease	9.51e-05	0.0128	CbGpPWpGaD
Dexamethasone—NOS2—IL12-mediated signaling events—HLA-DRB1—celiac disease	9.16e-05	0.0123	CbGpPWpGaD
Dexamethasone—SLCO1A2—SLC-mediated transmembrane transport—SLC9A4—celiac disease	9.02e-05	0.0121	CbGpPWpGaD
Dexamethasone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12A—celiac disease	8.63e-05	0.0116	CbGpPWpGaD
Dexamethasone—ANXA1—G alpha (i) signalling events—CCR3—celiac disease	8.35e-05	0.0112	CbGpPWpGaD
Dexamethasone—ANXA1—Class A/1 (Rhodopsin-like receptors)—CCR4—celiac disease	7.81e-05	0.0105	CbGpPWpGaD
Dexamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX3—celiac disease	7.59e-05	0.0102	CbGpPWpGaD
Dexamethasone—ABCG2—HIF-1-alpha transcription factor network—ETS1—celiac disease	7.06e-05	0.00949	CbGpPWpGaD
Dexamethasone—CYP19A1—Integrated Breast Cancer Pathway—ZMIZ1—celiac disease	6.9e-05	0.00928	CbGpPWpGaD
Dexamethasone—NR3C1—AP-1 transcription factor network—ETS1—celiac disease	6.78e-05	0.00912	CbGpPWpGaD
Dexamethasone—ANXA1—Class A/1 (Rhodopsin-like receptors)—CCR3—celiac disease	6.64e-05	0.00893	CbGpPWpGaD
Dexamethasone—NOS2—IL12-mediated signaling events—CD4—celiac disease	6.46e-05	0.00869	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—ARHGAP31—celiac disease	5.97e-05	0.00804	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR ligand binding—CCR4—celiac disease	5.95e-05	0.008	CbGpPWpGaD
Dexamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—celiac disease	5.37e-05	0.00723	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism—LCT—celiac disease	5.31e-05	0.00715	CbGpPWpGaD
Dexamethasone—NOS2—Hemostasis—PLEK—celiac disease	5.29e-05	0.00712	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR ligand binding—CCR3—celiac disease	5.06e-05	0.0068	CbGpPWpGaD
Dexamethasone—NOS2—Disease—LCT—celiac disease	4.88e-05	0.00656	CbGpPWpGaD
Dexamethasone—SLCO1A2—Transmembrane transport of small molecules—SLC9A4—celiac disease	4.58e-05	0.00617	CbGpPWpGaD
Dexamethasone—NR3C1—SIDS Susceptibility Pathways—RUNX3—celiac disease	4.49e-05	0.00604	CbGpPWpGaD
Dexamethasone—ABCB1—Allograft Rejection—IL12A—celiac disease	4.47e-05	0.00602	CbGpPWpGaD
Dexamethasone—PTGS2—C-MYB transcription factor network—ETS1—celiac disease	4.44e-05	0.00597	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR downstream signaling—RGS1—celiac disease	4.35e-05	0.00585	CbGpPWpGaD
Dexamethasone—NR3C1—AP-1 transcription factor network—IL10—celiac disease	4.21e-05	0.00567	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—LCT—celiac disease	4.18e-05	0.00563	CbGpPWpGaD
Dexamethasone—ABCC2—Transmembrane transport of small molecules—SLC9A4—celiac disease	4.17e-05	0.00562	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—RGS1—celiac disease	3.95e-05	0.00531	CbGpPWpGaD
Dexamethasone—ABCB1—HIF-1-alpha transcription factor network—ETS1—celiac disease	3.82e-05	0.00513	CbGpPWpGaD
Dexamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—celiac disease	3.75e-05	0.00504	CbGpPWpGaD
Dexamethasone—ABCG2—Transmembrane transport of small molecules—SLC9A4—celiac disease	3.63e-05	0.00488	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—MYO9B—celiac disease	3.62e-05	0.00487	CbGpPWpGaD
Dexamethasone—PTGS2—Spinal Cord Injury—FCGR2A—celiac disease	3.4e-05	0.00458	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR downstream signaling—CCR4—celiac disease	3.36e-05	0.00452	CbGpPWpGaD
Dexamethasone—NOS2—Hemostasis—SH2B3—celiac disease	3.32e-05	0.00447	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—ARHGAP31—celiac disease	3.27e-05	0.00439	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—LCT—celiac disease	3.2e-05	0.00431	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—TAGAP—celiac disease	3.14e-05	0.00422	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—CCR4—celiac disease	3.05e-05	0.0041	CbGpPWpGaD
Dexamethasone—ABCB1—Allograft Rejection—IL17A—celiac disease	3.02e-05	0.00407	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—LCT—celiac disease	2.93e-05	0.00394	CbGpPWpGaD
Dexamethasone—PGR—Signaling by ERBB4—CD80—celiac disease	2.92e-05	0.00392	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—LCT—celiac disease	2.9e-05	0.0039	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR downstream signaling—CCR3—celiac disease	2.86e-05	0.00384	CbGpPWpGaD
Dexamethasone—ABCB1—Allograft Rejection—HLA-DPB1—celiac disease	2.79e-05	0.00375	CbGpPWpGaD
Dexamethasone—ABCB1—Allograft Rejection—CTLA4—celiac disease	2.64e-05	0.00355	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—CCR3—celiac disease	2.59e-05	0.00349	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—LCT—celiac disease	2.57e-05	0.00346	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—RGS1—celiac disease	2.33e-05	0.00314	CbGpPWpGaD
Dexamethasone—ABCB1—Allograft Rejection—HLA-DQA1—celiac disease	2.33e-05	0.00313	CbGpPWpGaD
Dexamethasone—NR3C1—SIDS Susceptibility Pathways—IL10—celiac disease	2.22e-05	0.00298	CbGpPWpGaD
Dexamethasone—ABCB1—Allograft Rejection—HLA-DQB1—celiac disease	2.18e-05	0.00293	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—LCT—celiac disease	2.15e-05	0.00289	CbGpPWpGaD
Dexamethasone—ABCB1—Allograft Rejection—IL10—celiac disease	2.05e-05	0.00276	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—MYO9B—celiac disease	1.98e-05	0.00266	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—SLC9A4—celiac disease	1.96e-05	0.00264	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—LCT—celiac disease	1.94e-05	0.00261	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—LCT—celiac disease	1.87e-05	0.00251	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—CCR4—celiac disease	1.8e-05	0.00242	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—TAGAP—celiac disease	1.72e-05	0.00231	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—LCT—celiac disease	1.7e-05	0.00229	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—LCT—celiac disease	1.69e-05	0.00227	CbGpPWpGaD
Dexamethasone—ABCB1—Allograft Rejection—HLA-DRB1—celiac disease	1.65e-05	0.00223	CbGpPWpGaD
Dexamethasone—PTGS2—C-MYB transcription factor network—CD4—celiac disease	1.57e-05	0.00211	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—LCT—celiac disease	1.55e-05	0.00208	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—LCT—celiac disease	1.54e-05	0.00208	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—CCR3—celiac disease	1.53e-05	0.00206	CbGpPWpGaD
Dexamethasone—ABCB1—Allograft Rejection—CD80—celiac disease	1.53e-05	0.00206	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—SH2B3—celiac disease	1.49e-05	0.00201	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—LCT—celiac disease	1.3e-05	0.00174	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—RGS1—celiac disease	1.28e-05	0.00172	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—LCT—celiac disease	1.25e-05	0.00168	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—LCT—celiac disease	1.22e-05	0.00164	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—LCT—celiac disease	1.22e-05	0.00164	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—LCT—celiac disease	1.15e-05	0.00155	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—LCT—celiac disease	1.06e-05	0.00142	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CCR4—celiac disease	9.85e-06	0.00133	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—LCT—celiac disease	9.42e-06	0.00127	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—LCT—celiac disease	9.19e-06	0.00124	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—LCT—celiac disease	8.66e-06	0.00117	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—LCT—celiac disease	8.59e-06	0.00116	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CCR3—celiac disease	8.38e-06	0.00113	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—SH2B3—celiac disease	8.17e-06	0.0011	CbGpPWpGaD
Dexamethasone—NOS2—Disease—CD80—celiac disease	7.44e-06	0.001	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—CD80—celiac disease	6.91e-06	0.000929	CbGpPWpGaD
Dexamethasone—NOS2—Disease—CD4—celiac disease	5.68e-06	0.000764	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—LCT—celiac disease	5.66e-06	0.000762	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CD80—celiac disease	3.78e-06	0.000508	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CD80—celiac disease	2.36e-06	0.000318	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CD4—celiac disease	1.8e-06	0.000243	CbGpPWpGaD
